Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 6156217, 7 pages
http://dx.doi.org/10.1155/2016/6156217
Clinical Study

Vitamin D Deficiency Is Not Associated with Diabetic Retinopathy or Maculopathy

1Centre for Endocrinology and Diabetes, Institute of Human Development, University of Manchester and the Manchester Royal Infirmary, Central Manchester Hospital Foundation Trust, Manchester M13 9NT, UK
2Department of Medicine, Barts and the London School of Medicine and Dentistry, London E1 2AD, UK
3Weill Cornell Medical College in Qatar, Doha, Qatar

Received 26 July 2015; Accepted 5 October 2015

Academic Editor: Roberto Mallone

Copyright © 2016 Uazman Alam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. W. Y. Yau, S. L. Rogers, R. Kawasaki et al., “Global prevalence and major risk factors of diabetic retinopathy,” Diabetes Care, vol. 35, no. 3, pp. 556–564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Bunce and R. Wormald, “Leading causes of certification for blindness and partial sight in England & Wales,” BMC Public Health, vol. 6, article 58, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Resnikoff, D. Pascolini, D. Etya'ale et al., “Global data on visual impairment in the year 2002,” Bulletin of the World Health Organization, vol. 82, no. 11, pp. 844–851, 2004. View at Google Scholar · View at Scopus
  4. C. Joergensen, P. Hovind, A. Schmedes, H.-H. Parving, and P. Rossing, “Vitamin D levels, microvascular complications, and mortality in type 1 diabetes,” Diabetes Care, vol. 34, no. 5, pp. 1081–1085, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Ismail-Beigi, T. Craven, M. A. Banerji et al., “Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial,” The Lancet, vol. 376, no. 9739, pp. 419–430, 2010. View at Publisher · View at Google Scholar
  6. F. Ismail-Beigi, T. E. Craven, P. J. O'Connor et al., “Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients,” Kidney International, vol. 81, no. 6, pp. 586–594, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. H.-P. Hammes, Y. Feng, F. Pfister, and M. Brownlee, “Diabetic retinopathy: targeting vasoregression,” Diabetes, vol. 60, no. 1, pp. 9–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. C.-T. C. Lee, E. L. Gayton, J. W. J. Beulens, D. W. Flanagan, and A. I. Adler, “Micronutrients and diabetic retinopathy a systematic review,” Ophthalmology, vol. 117, no. 1, pp. 71–78, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. F. Holick, “Medical progress: vitamin D deficiency,” The New England Journal of Medicine, vol. 357, no. 3, pp. 266–281, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. T. J. Wang, M. J. Pencina, S. L. Booth et al., “Vitamin D deficiency and risk of cardiovascular disease,” Circulation, vol. 117, no. 4, pp. 503–511, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Bućan, M. Ivanišević, T. Zemunik et al., “Retinopathy and nephropathy in type 1 diabetic patients—association with polymorphysms of vitamin D-receptor, TNF, Neuro-D and Il-1 receptor 1 genes,” Collegium Antropologicum, vol. 33, supplement 2, pp. 99–105, 2009. View at Google Scholar · View at Scopus
  12. M. J. Taverna, J.-L. Selam, and G. Slama, “Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptide-negative type 1 diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 8, pp. 4803–4808, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Taverna, A. Sola, C. Guyot-Argenton et al., “Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy,” Diabetologia, vol. 45, no. 3, pp. 436–442, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Verstappen, M. Parmentier, M. Chirnoaga, D. E. Lawson, J. L. Pasteels, and R. Pochet, “Vitamin D-dependent calcium binding protein immunoreactivity in human retina,” Ophthalmic Research, vol. 18, no. 4, pp. 209–214, 1986. View at Publisher · View at Google Scholar · View at Scopus
  15. T. A. Craig, S. Sommer, C. R. Sussman, J. P. Grande, and R. Kumar, “Expression and regulation of the vitamin D receptor in the zebrafish, Danio rerio,” Journal of Bone and Mineral Research, vol. 23, no. 9, pp. 1486–1496, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Wagner, K.-D. Wagner, G. Schley, L. Badiali, H. Theres, and H. Scholz, “1,25-Dihydroxyvitamin D3-induced apoptosis of retinoblastoma cells is associated with reciprocal changes of Bcl-2 and bax,” Experimental Eye Research, vol. 77, no. 1, pp. 1–9, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Cardus, S. Panizo, M. Encinas et al., “1,25-Dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter,” Atherosclerosis, vol. 204, no. 1, pp. 85–89, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Panou, S. Georgopoulos, T. N. Sergentanis, A. Papalampros, M. Maropoulos, and N. Tentolouris, “Serum 25(OH)D and VEGF in diabetes mellitus type 2: gender-specific associations,” International Journal of Collaborative Research on Internal Medicine & Public Health, vol. 3, pp. 790–795, 2011. View at Google Scholar
  19. D. M. Albert, E. A. Scheef, S. Wang et al., “Calcitriol is a potent inhibitor of retinal neovascularization,” Investigative Ophthalmology & Visual Science, vol. 48, no. 5, pp. 2327–2334, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. O. Kordonouri, A. Wladimirowa, and T. Danne, “High total serum renin concentrations are associated with the development of background retinopathy in adolescents with type 1 diabetes,” Diabetes Care, vol. 23, no. 7, pp. 1025–1026, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Harindhanavudhi, M. Mauer, R. Klein, B. Zinman, A. Sinaiko, and M. L. Caramori, “Benefits of renin-angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control,” Diabetes Care, vol. 34, no. 8, pp. 1838–1842, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Ireland, “Diabetic nephropathy: paricalcitol lowers residual albuminuria in type 2 diabetes,” Nature Reviews Nephrology, vol. 7, article 62, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Aksoy, F. Akçay, N. Kurtul, O. Baykal, and B. Avci, “Serum 1,25 dihydroxy vitamin D (1,25(OH)2D3), 25 hydroxy vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy,” Clinical Biochemistry, vol. 33, no. 1, pp. 47–51, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Kaur, K. C. Donaghue, A. K. Chan et al., “Vitamin D deficiency is associated with retinopathy in children and adolescents with type 1 diabetes,” Diabetes Care, vol. 34, no. 6, pp. 1400–1402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. F. Payne, R. Ray, D. G. Watson et al., “Vitamin D insufficiency in diabetic retinopathy,” Endocrine Practice, vol. 18, no. 2, pp. 185–193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. P. A. Patrick, P. F. Visintainer, Q. Shi, I. A. Weiss, and D. A. Brand, “Vitamin D and retinopathy in adults with diabetes mellitus,” Archives of Ophthalmology, vol. 130, no. 6, pp. 756–760, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. P. H. Scanlon, “The English national screening programme for sight-threatening diabetic retinopathy,” Journal of Medical Screening, vol. 15, no. 1, pp. 1–4, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Patra, E. M. W. Gomm, M. Macipe, and C. Bailey, “Interobserver agreement between primary graders and an expert grader in the Bristol and Weston diabetic retinopathy screening programme: a quality assurance audit,” Diabetic Medicine, vol. 26, no. 8, pp. 820–823, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. U. Alam, O. Najam, S. Al-Himdani et al., “Marked vitamin D deficiency in patients with diabetes in the UK: ethnic and seasonal differences and an association with dyslipidaemia,” Diabetic Medicine, vol. 29, no. 10, pp. 1343–1345, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. H. F. Deluca and M. T. Cantorna, “Vitamin D: its role and uses in immunology,” The FASEB Journal, vol. 15, no. 14, pp. 2579–2585, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Zoppini, A. Galletti, G. Targher et al., “Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes,” BMJ Open Diabetes Research & Care, vol. 3, no. 1, Article ID e000058, 2015. View at Publisher · View at Google Scholar
  32. L. Engelen, C. G. Schalkwijk, S. J. Eussen et al., “Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study,” Cardiovascular Diabetology, vol. 14, article 67, 2015. View at Publisher · View at Google Scholar